US Stock MarketDetailed Quotes

REVIVE THERAPEUTICS LTD (RVVTF)

Watchlist
  • 0.0296
  • +0.0016+5.71%
15min DelayClose Apr 24 15:52 ET
12.90MMarket Cap-1.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

REVIVE THERAPEUTICS LTD (RVVTF) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.90%280.48K
-59.94%218.11K
-49.83%1.65M
43.49%334.81K
-74.10%480.59K
-63.13%288.87K
55.13%544.45K
-40.48%3.29M
-34.28%233.33K
-5.31%1.86M
Selling and administrative expenses
1.72%274.74K
-46.66%205.86K
-31.94%1.4M
127.41%321.83K
-69.55%420.93K
-3.13%270.1K
103.01%385.92K
15.89%2.06M
-33.76%141.52K
59.43%1.38M
-Selling and marketing expense
--0
46.24%35K
-9.95%62.07K
--0
-89.36%13.94K
--24.2K
--23.93K
-78.02%68.93K
---62.07K
-58.23%131K
-General and administrative expense
11.73%274.74K
-52.80%170.86K
-32.70%1.34M
58.08%321.83K
-67.47%406.99K
-11.81%245.91K
90.42%361.99K
36.07%1.99M
-4.71%203.59K
126.14%1.25M
Research and development costs
--0
--0
-86.96%144.81K
--0
--0
--0
8.56%144.81K
-69.01%1.11M
-39.87%71.75K
-55.53%471.96K
Depreciation amortization depletion
-22.58%48
-25.81%46
-24.39%248
-24.39%62
-24.39%62
-24.39%62
-24.39%62
-24.42%328
-24.77%82
-24.07%82
-Depreciation and amortization
-22.58%48
-25.81%46
-24.39%248
-24.39%62
-24.39%62
-24.39%62
-24.39%62
-24.42%328
-24.77%82
-24.07%82
Other operating expenses
-69.56%5.69K
-10.69%12.2K
-12.76%104.88K
-35.33%12.92K
4,093.74%59.59K
-73.81%18.71K
-50.15%13.66K
-26.69%120.22K
-8.86%19.98K
-95.45%1.42K
Operating profit
2.90%-280.48K
59.94%-218.11K
49.83%-1.65M
-43.49%-334.81K
74.10%-480.59K
63.13%-288.87K
-55.13%-544.45K
40.48%-3.29M
34.28%-233.33K
5.31%-1.86M
Net non-operating interest income expense
-814.61%-2.82K
-507.48%-1.74K
-105.94%-2.3K
-161.80%-1.58K
-382.83%-840
-102.38%-308
-98.13%428
-40.12%38.69K
-90.52%2.56K
-98.09%297
Non-operating interest income
--0
-80.00%277
-97.68%1.44K
--0
--0
-99.74%51
-95.59%1.39K
-45.05%61.98K
-84.55%5.69K
-80.04%5.3K
Non-operating interest expense
--0
--0
-96.85%632
--0
--0
--0
-91.55%632
-54.33%20.1K
-72.35%2.48K
-59.16%4.23K
Total other finance cost
684.68%2.82K
521.85%2.02K
-2.82%3.1K
141.44%1.58K
9.38%840
-53.68%359
-67.37%325
-23.52%3.19K
-27.65%654
21.71%768
Other net income (expense)
159.02%44.58K
-186.56%-61.9K
-294.74%-9.36M
-293.29%-9.26M
-476.17%-95.75K
-75.53K
214.30%71.51K
-174.29%-2.37M
-2.35M
-16.62K
Gain on sale of security
129.84%44.58K
-186.56%-61.9K
-138.11%-55.76K
-35.56%117.87K
-161.49%-95.75K
---149.38K
214.30%71.51K
267.18%146.28K
--182.9K
---36.62K
Special income (charges)
--0
----
-269.59%-9.3M
-269.58%-9.38M
--0
--73.85K
----
-224.01%-2.52M
-226.58%-2.54M
--20K
-Less:Impairment of capital assets
----
----
300.00%9.38M
----
----
----
----
201.75%2.34M
----
----
-Less:Other special charges
----
----
-269.25%-73.85K
--0
----
---73.85K
----
---20K
--0
---20K
-Gain on sale of business
----
----
--0
----
----
----
----
---192.95K
----
----
Income before tax
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Income tax
Net income
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Net income continuous Operations
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Minority interest income
Net income attributable to the parent company
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Basic earnings per share
0
0
-200.00%-0.03
-0.03
0
0
0
50.00%-0.01
0
0
Diluted earnings per share
0
0
-200.00%-0.03
-0.03
0
0
0
50.00%-0.01
0
0
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.90%280.48K-59.94%218.11K-49.83%1.65M43.49%334.81K-74.10%480.59K-63.13%288.87K55.13%544.45K-40.48%3.29M-34.28%233.33K-5.31%1.86M
Selling and administrative expenses 1.72%274.74K-46.66%205.86K-31.94%1.4M127.41%321.83K-69.55%420.93K-3.13%270.1K103.01%385.92K15.89%2.06M-33.76%141.52K59.43%1.38M
-Selling and marketing expense --046.24%35K-9.95%62.07K--0-89.36%13.94K--24.2K--23.93K-78.02%68.93K---62.07K-58.23%131K
-General and administrative expense 11.73%274.74K-52.80%170.86K-32.70%1.34M58.08%321.83K-67.47%406.99K-11.81%245.91K90.42%361.99K36.07%1.99M-4.71%203.59K126.14%1.25M
Research and development costs --0--0-86.96%144.81K--0--0--08.56%144.81K-69.01%1.11M-39.87%71.75K-55.53%471.96K
Depreciation amortization depletion -22.58%48-25.81%46-24.39%248-24.39%62-24.39%62-24.39%62-24.39%62-24.42%328-24.77%82-24.07%82
-Depreciation and amortization -22.58%48-25.81%46-24.39%248-24.39%62-24.39%62-24.39%62-24.39%62-24.42%328-24.77%82-24.07%82
Other operating expenses -69.56%5.69K-10.69%12.2K-12.76%104.88K-35.33%12.92K4,093.74%59.59K-73.81%18.71K-50.15%13.66K-26.69%120.22K-8.86%19.98K-95.45%1.42K
Operating profit 2.90%-280.48K59.94%-218.11K49.83%-1.65M-43.49%-334.81K74.10%-480.59K63.13%-288.87K-55.13%-544.45K40.48%-3.29M34.28%-233.33K5.31%-1.86M
Net non-operating interest income expense -814.61%-2.82K-507.48%-1.74K-105.94%-2.3K-161.80%-1.58K-382.83%-840-102.38%-308-98.13%428-40.12%38.69K-90.52%2.56K-98.09%297
Non-operating interest income --0-80.00%277-97.68%1.44K--0--0-99.74%51-95.59%1.39K-45.05%61.98K-84.55%5.69K-80.04%5.3K
Non-operating interest expense --0--0-96.85%632--0--0--0-91.55%632-54.33%20.1K-72.35%2.48K-59.16%4.23K
Total other finance cost 684.68%2.82K521.85%2.02K-2.82%3.1K141.44%1.58K9.38%840-53.68%359-67.37%325-23.52%3.19K-27.65%65421.71%768
Other net income (expense) 159.02%44.58K-186.56%-61.9K-294.74%-9.36M-293.29%-9.26M-476.17%-95.75K-75.53K214.30%71.51K-174.29%-2.37M-2.35M-16.62K
Gain on sale of security 129.84%44.58K-186.56%-61.9K-138.11%-55.76K-35.56%117.87K-161.49%-95.75K---149.38K214.30%71.51K267.18%146.28K--182.9K---36.62K
Special income (charges) --0-----269.59%-9.3M-269.58%-9.38M--0--73.85K-----224.01%-2.52M-226.58%-2.54M--20K
-Less:Impairment of capital assets --------300.00%9.38M----------------201.75%2.34M--------
-Less:Other special charges ---------269.25%-73.85K--0-------73.85K-------20K--0---20K
-Gain on sale of business ----------0-------------------192.95K--------
Income before tax 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Income tax
Net income 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Net income continuous Operations 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Minority interest income
Net income attributable to the parent company 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Basic earnings per share 00-200.00%-0.03-0.0300050.00%-0.0100
Diluted earnings per share 00-200.00%-0.03-0.0300050.00%-0.0100
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -